InterVenn Company
InterVenn Biosciences identifies, quantifies and classifies Glycoproteomic and other PTM signals found in human blood and tissue.
.png)
(Reupload).png)
Technology:
Other
Industry:
P4 Medicine
Headquarters:
United States
Investors Number:
7
Total Funding:
$127.8M
Estimated Revenue:
$50M to $100M
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership